The Innovative Medicines Initiative (IMI) has launched a call for proposals from the scientific community to help it create a large chemogenomics library for drug discovery, access to which would be unrestricted.
The project is one of three announced on 22 January which will have a budget of more than €80 million. The other two projects are on obesity and the environmental impacts of medicines. The library project is directed at the wider academic community, many of whom do not have access to proprietary tool compounds collected by industry.